Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2472 of 6351
-
Could a simple pill replace the needle for kids with bone infections?
Disease control Recruiting nowThis is a multi- centre trial of children with bone and joint infections (BJIs) at eight major paediatric hospitals in Australia and New Zealand. The primary objective is to establish if in children with acute, uncomplicated BJIs, entirely oral antibiotic treatment is not inferio…
Phase 4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New monitoring method may ease pain after ovarian cancer surgery
Symptom relief OngoingThis is a single-center, randomized, phase II, non-comparative, single-blind clinical study that will determine whether morphine reduction through intraoperative monitoring by ANI (Analgesia Nociception Index) significantly reduces chronic post-surgical pain at three months after…
Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could an herbal patch ease pain after cancer?
Symptom relief OngoingThe purpose of this study is to find out whether Tibetree Pain Relieving Plaster, an herbal pain relief patch, may be able to reduce this pain. Tibetree Pain Relieving Plaster is available as an over-the-counter (non-prescription) treatment for the temporary relief of minor aches…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple antibody test predict severe COVID-19?
Knowledge-focused Recruiting nowIn January 2020, researchers isolated and sequenced in China from patients with severe atypical pneumonia a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread throughou…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to shrink spleen and ease symptoms in hard-to-treat myelofibrosis
Disease control Stopped earlyThe purpose of the study is to compare the efficacy and safety of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis who have suboptimal response while receiving ruxolitinib monotherapy.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Blood test could transform liver transplant monitoring
Knowledge-focused OngoingThe objective of this protocol is to conduct longitudinal and prospective studies of liver transplant recipients, using a multimodality approach, akin to that used in kidney transplantation. The primary aim will compare the clinical outcomes of LiverCare post-transplant surveilla…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Sanofi's COVID vaccine trial ends early – what we know
Vaccine Stopped earlyThe purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent) as part of primary series vaccinations in a multi-stage approach, as well as a booster injection of a CoV2 preS dTM-AS03 vaccine,…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
Can a smartphone app reveal how CF treatments really work at home?
Knowledge-focused CompletedThis is an observational cohort study, using data from Folia Health and the Cystic Fibrosis Foundation Patient Registry (CFFPR). Individuals taking elexacaftor/tezacaftor/ivacaftor (ETI) may be enrolled through the Folia application. During the 12-month study period, participants…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Oil flush may boost fertility in women with blocked tubes
Disease control OngoingTen to 15 percent of couples in their reproductive lifetime face fertility problems which is defined by WHO as the absence of pregnancy after minimal 12 months of unprotected sexual intercourse. The three most frequent causes of subfertility are: sperm defects, ovulation disorder…
Phase 4 • Sponsor: Dafne Balemans • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Myelofibrosis drug combo trial ends early – what it means
Disease control Stopped earlyThe purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood thinner may boost success of reattached fingers
Disease control Recruiting nowThe purpose of this study is to determine the effectiveness of therapeutic dose intravenous heparin at improving replantation/revascularization success and its indications (if any) in participants who have suffered traumatic digital amputation. Digital replantation/revascularizat…
Phase 4 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
AI watches over ICU patients to detect pain and confusion
Knowledge-focused Recruiting nowImportant information related to the visual assessment of patients, such as facial expressions, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses, or are not captured at all. Consequently, these important visual cues, although as…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New study tests better ways to fix dangerous aortic bulges
Disease control Recruiting nowThe aim of this randomized study is to compare the safety and performance of EndoVascular Aneurysm Repair with ESAR using Endurant + Heli-FX™ EndoAnchor™ system and FEVAR using customizable grafts from Cook (Zenith Fenestrated Graft) and Terumo (Fenestrated Anaconda Graft) for th…
Sponsor: FCRE (Foundation for Cardiovascular Research and Education) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a common cholesterol drug boost brain blood flow in early memory loss?
Disease control Recruiting nowThe purpose of this study is to evaluate the effect of atorvastatin on brain vessel reactivity and with it on blood flow in people with mild cognitive impairment.
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for kids with tough leukemia: experimental combo tested
Disease control CompletedThis phase I trial studies the best dose and side effects of liposomal cytarabine, daunorubicin, and gemtuzumab ozogamicin in treating pediatric patients with acute myeloid leukemia that has returned after treatment (relapsed) or does not respond to treatment (refractory). Chemot…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Heated chemo during second surgery shows promise for ovarian cancer
Disease control CompletedThe purpose of this research study is to see if it is feasible to receive heated chemotherapy or heated intraperitoneal chemotherapy (HIPEC) inserted directly into the abdomen at the time of a Second Look Reassessment Surgery and to monitor any effects good or bad that this has o…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug could protect children with cancer from chemo side effects
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.
Phase 2 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a common blood pressure pill boost immunotherapy for bladder cancer?
Disease control OngoingThis research study is an open label study designed to evaluate the safety and translational correlative changes of the combination of propranolol hydrochloride and immune checkpoint inhibitors (ICI) in subjects with urothelial carcinoma.
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Mind over pain: new study tests Brain-Based therapy for back pain
Symptom relief Recruiting nowThe goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating ba…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Tailored chemo dosing aims to boost stem cell transplant success in myeloma
Disease control Recruiting nowThis phase I trial studies the best dose and side effects of mephalan in treating patients with multiple myeloma who are undergoing stem cell transplant. Chemotherapy drugs, such as mephalan, work in different ways to stop the growth of cancer cells, either by killing the cells, …
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC